We assessed the early and mid-term results of the modified Norwood procedure for first-stage palliation of hypoplastic left heart syndrome (HLHS) and its variants to identify the risk factors for hospital mortality. Material and Method : Between March, 2003, and December, 2009, 23 patients (18 males and 5 females) with HLHS or variants underwent the modified Norwood procedure. The age at operation ranged from 3 to 60 days (mean, 11.7±13.2 days) and weight at operation ranged from 2.2 to 4.8 kg (mean, 3.17±0.52 kg). We used a modified technique that spared the anterior wall of the main pulmonary artery in 20 patients. The sources of pulmonary blood flow were RV-PA conduit in 15 patients (group I) and RMBTS in 8 (group II). Follow-up was completed in 19 patients (19/20, 95%) in our hospital (mean 26.0±22.8 months). Result: Early death occurred in 3 patients (3/23, 13%), of whom 2 had TAPVC. Fourteen patients underwent subsequent bidirectional cavopulmonary connection (BCPC, stage 2) and seven underwent the Fontan operation (stage 3). Three patients died between stages, 2 before stage 2 and one before stage 3. The estimated 1-year and 5-year survival rates were 78% and 69%, respectively. On multivariate regression analysis, aberrant right subclavian artery (RSCA) and associated total anomalous pulmonary venous connection (TAPVC) were risk factors for hospital mortality after stage 1 Norwood procedure. Conclusion: HLHS and its variants can be palliated by the modified Norwood procedure with low operative mortality. Total anomalous pulmonary venous connection adversely affects the survival after a stage 1 Norwood procedure, and interstage mortality rates need to be improved. 
INTRODUCTION
Since Norwood, Lang, and Hansen [1] first reported a successful application of palliative staged approach for hypoplastic left heart syndrome (HLHS) in 1983, the outlook for the patients with HLHS has dramatically improved [2, 3] . However, the Norwood procedure as a stage I palliation still remains a challenging step with a high mortality [4, 5] . This phenomenon has been implicated as a major cause of early death in these infants [3] .
In the classic Norwood procedure, the main pulmonary artery (MPA) is transected at its proximal portion and the neoaorta is reconstructed with a homograft or other nonviable material, which might limit the growth potential of the neoaorta. In order to solve this problem, some surgeons reconstruct the neoaorta with only autologous tissue [6] .
However, besides being technically demanding, this technique can narrow the space for the pulmonary arteries behind the neoaorta and cause left bronchial compression, reducing the success rate of the Fontan procedure. To avoid these problems, we developed technical modification sparing anterior wall of main pulmonary artery in neoaortic reconstruction [7] .
The purpose of the present study was to assess the early and mid-term results of the modified Norwood procedure during last 7 years in our hospital. We excised both pulmonary arteries from the posterior wall of the MPA in a single U-shaped large button to spare the large anterior MPA wall (Fig. 1B) . The two openings of right and left pulmonary arteries were covered with redundant bovine pericardial patch. The pulmonary artery isolation was performed under beating heart. The distal ascending aorta was transected at just proximal to the innominate artery and cardiplegia was then induced by direct infusion of the cold blood cardioplegic solution into the divided small ascending aorta.
MATERIAL AND METHOD
A long longitudinal incision at the ascending aorta and a small vertical incision at the MPA were made, respectively, at their corresponding sites, and the longitudinally incised ascending aorta was incorporated to the MPA. The defect cre- Finally, RV-PA conduit was performed in 15 patients (group I), and RMBTS in 8 patients (group II) as a source of pulmonary blood flow. In the RV-PA conduit group, the size of the shunt used was 5 mm in 5 patients, and 6 mm in 10 patients. In the RMBTS group, all patients was used 3.5 mm PTFE tube graft, and RMBTS was banded using a 3.5 mm PTFE tube graft strip in 5 patients. Preoperative profiles of each patient group are shown in Table 2 . Ventilator settings were adjusted to keep arterial oxygen saturations between 75% and 85% and carbon dioxide levels from 40 to 50 mmHg. Hemoglobin level was kept over 15 g/dL.
The inotropic drugs mostly used were dopamine or dobutamine 5 to 10μg/kg per minute, milrinone 0.35 to 0.7μg/kg per minute, and calcium gluconate 10 mg/kg per hour.
Vasopressin 0.0001 to 0.0006 u/kg per minute was also used to regulate systemic vascular resistance. Table 3 . CPB time was significantly longer in the RV-PA conduit group.
− 369 − There were 3 early hospital mortalities (3/23, 13.0%).
Among them 2 occurred in the patients with TAPVC. The causes of deaths are depicted in Table 4 . We analysed the risk factors for hospital mortality. Univariate analysis identified sex, aberrant right subclavian artery (RSCA), aortic arch anomaly, and associated TAPVC as significant risk factors.
On multivariate regression analysis, aberrant RSCA and associated TAPVC were independently associated with hospital mortality after the Norwood procedure (Table 5) . were 78%, 69%, and 69% at 1, 3, and 5 years after surgery respectively (Fig. 3A) . For the patients who underwent a RV-PA conduit during the Norwood procedure (group I), survival at 6 months was 73% and 73% at 1 year compared with 86% at 6 months and 86% at 1 year for those who underwent a RMBTS (group II) (p=0.405, log rank test) (Fig.   3B ).
2) Late follow-up data

DISCUSSION
In our 7-year experience with our modified Norwood procedure, the early survival rate was 87% (20/23). The 1-year Fig. 2 . The current status of all patients after the Norwood procedure for hypoplastic left heart syndrome. BCPC=Bidirectional cavopulmonary connection; *=One patient who underwent the Fontan operation had been transferred to other hospital after the Norwood procedure.
and 5-year survival rates were 78% and 69%, respectively.
We found that aberrant RSCA and associated TAPVC were independent risk factors associated with early mortality.
The Norwood procedure has been known as one of the most challenging cardiac anomalies for neonatal cardiac operations, because operative success needs precise anesthetic and cardiopulmonary bypass for brain and myocardial protections and meticulous postoperative management for single ventricular physiology. Only a few centers in North America were able to reproduce some outcomes in the past, but there was a significant improvement in the outcome with the Norwood procedure in recent years. Early mortality was about 30∼35% in series in the early to middle 1990s but has improved, and some large centers are now reporting early survival of 85∼90% [8] [9] [10] . The operative survival of our series showed also good early results (20/23, 87%).
1) The technical modification of the neoaortic reconstruction
Neoaortic reconstruction is an important part in the stage I Norwood procedure. The neoaortic reconstruction using nonviable material can yield several problems, such as no growth potential, calcification, and aneurysmal change [11, 12] . The reconstruction without additional patch material can make the short and big neoaorta which can cause pulmonary artery and bronchial compression. Our technique was developed to minimize these future potential problems by incorporating the abundant anterior wall of the MPA to the neoaortic reconstruction. The right and left pulmonary arteries arise together from the posterior wall of the MPA without any gap between the openings of both pulmonary arteries (Fig. 1A) . We utilized these anatomic characteristics. By separating both pulmonary arteries from the posterior wall of MPA in the U-shaped button instead of MPA transection we can use its anterior wall in the reconstruction of neoarota. Our technical modifications maximize the use of autologous tissues for the neoaortic reconstruction and save more space for pulmonary arteries and left bronchus behind the neoaorta, which is very important for later successful BCPC and Fontan operation.
2) Factors associated with outcomes
There has been extensive analysis of the risk factors asso- ciated with the Norwood procedure. The most frequently cited risk factors are the small size of the ascending aorta [13] , low birth weight [14] , significant tricuspid regurgitation [15] , intact or restrictive atrial septum, and pre-existing impaired ventricular function. The presence of syndrome or other genetic defects is also strongly associated with poor outcome [16] .
The anatomic subtypes of HLHS, especially aortic atresia, have been considered as a risk factor for poor outcome [17] .
In the present study, we were able to find that aberrant RSCA and associated TAPVC were independent risk factors associated with early mortality. The aberrant RSCA from the descending aorta prevents an extensive mobilization of the descending aorta and thus makes the anastomosis between the MPA and aortic arch difficult [6] . Children with the aberrant RSCA probably benefit from RV-PA conduit because the patient who has the aberrant RSCA usually has small innominate artery [18] . Hospital survival after the Norwood procedure is significantly worse among the patients with severe obstruction to pulmonary venous return, as reported by Bove and colleagues [19] , and the patients with associated TAPVC have more probability of obstruction to pulmonary venous return. Two patients underwent concomitant TAPVC repairs during the Norwood procedure, and all of these patients died 6 days and 3 days after the operation, respectively. One patient died of hypoxemia due to pulmonary hypertension, and the other patient due to low cardiac output and pump weaning failure.
3) Interstage mortality
The persistent incidence of interstage death is of great concern, especially during the first year of life among patients who survived the initial hospitalization. Gaynor and colleagues [20] reported that 12% of the survivors of the initial procedure died before 1 year of age, mostly before the BCPC. These deaths are usually sudden and often unexpected [21] . Residual aortic arch obstruction, restrictive atrial septal defects, imbalance of pulmonary and systemic blood flow, diastolic run-off with coronary ischemia, shunt stenosis of thrombosis, and chronic volume overload of the single ventricle have all been implicated as possible causes for interstage mortality [22] . However, the only identifiable preoperative findings predictive of interstage mortality are restrictive atrial septum and late initial presentation [23] .
In this study, the interstage mortality is still significant; 3 This simple measure reduces interstage mortality in one study [24] . Philadelphia by Ballweg and coworkers [25] , there is no difference in survival at 3 years. Given that overall survival was not different at the current report, we need more long-term follow-up data from the randomized study to understand which surgical strategy will be better, or more suitable for which subset of patients.
5) Study limitation
Several limitations of the present study require consideration. First, this study involved a relatively small number of patients, which may explain that it is difficult to find some risk factors for mortality, but we were able to find early and mid-term results themselves for our modified Norwood procedure. Second, follow-up periods were different between RV-PA conduit patients and RMBTS patients (RV-PA conduit; 38±22 months versus RMBTS; 10±9 months, p=0.002).
The RV-PA conduit group included the early experiences in our institution. However, we were able to compare the early results between RV-PA conduit patients (Group I) and RMBTS patients (Group II). Third, the effect of general improvement in surgical technique and perioperative care as experience accumulated could not be analyzed in the study.
CONCLUSION
In conclusion, the modified Norwood procedure can be performed for the first stage palliation of the hypoplastic left heart syndrome and its variants with low operative mortality comparable to the outcomes from other large centers. Our technical modification sparing the anterior wall of MPA is feasible in the neoaortic reconstruction of the Norwood procedure. An association of total anomalous pulmonary venous connection adversely affects the outcome of the Norwood procedure. More efforts should be paid to reduce the interstage mortality.
